Absci Corp

ABSI · Nasdaq · SIC 8731: Services-Commercial Physical & Biological Research · Market Cap: $0.8B · 140 employees
89
SEC Filings
$6.52
Close 2026-06-01
140
Employees

Business Summary

Overview We are a clinical-stage biopharmaceutical company using an AI-native approach to develop differentiated antibody therapeutics. Our integrated drug creation platform combines Origin-1, our generative design model, with rapid validation using our lab-in-the-loop. We focus on underexplored mechanisms where unmet medical need is high and competition is low. We have advanced our first two programs from AI design to IND (or foreign equivalent) in around two years with a total investment of ap...

Latest Stock Quote

ABSI 2026-06-01 $6.52 O:$6.73 H:$6.77 L:$6.38 Vol:5.0M VWAP:$6.5523
origin leaf: 83c8c31155d96709d86a8ae1ae11084f60b96a40da59c6eafc27c3aa83c94667

Next Earnings

Q2 FY2026 — expected 2026-08-12

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-242025-12-310001672688-26-000068EDGAR83K words
2025-03-182024-12-310001628280-25-013464EDGAR
2024-03-212023-12-310001628280-24-012366EDGAR
2023-03-302022-12-310001628280-23-009908EDGAR
2022-03-222021-12-310001628280-22-006925EDGAR

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-122025-09-300001672688-25-000084EDGAR56K words
2025-08-122025-06-300001628280-25-039938EDGAR
2025-05-132025-03-310001628280-25-025077EDGAR
2024-11-122024-09-300001628280-24-046862EDGAR
2024-08-142024-06-300001628280-24-037193EDGAR
2024-05-142024-03-310001628280-24-023062EDGAR
2023-11-142023-09-300001628280-23-038983EDGAR
2023-08-142023-06-300001628280-23-029197EDGAR
2023-05-152023-03-310001628280-23-018165EDGAR
2022-11-092022-09-300001628280-22-029092EDGAR
2022-08-112022-06-300001628280-22-022331EDGAR
2022-05-112022-03-310001628280-22-013760EDGAR

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-240001672688-26-000066EDGAR3K words
2026-03-060001672688-26-000047EDGAR
2026-01-140001672688-26-000003EDGAR
2025-11-120001672688-25-000082EDGAR
2025-11-040001672688-25-000076EDGAR
2025-08-120001628280-25-039878EDGAR
2025-07-250001193125-25-165466EDGAR
2025-07-080001628280-25-034544EDGAR
2025-06-120001628280-25-030953EDGAR
2025-05-130001628280-25-025075EDGAR

89 total filings indexed. 62 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

CRL — CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CBIH — Cannabis Bioscience International Holdings, Inc. FOXO — FOXO TECHNOLOGIES INC. INCY — INCYTE CORP IQV — IQVIA HOLDINGS INC. NOTV — Inotiv, Inc. MXCT — MAXCYTE, INC. MEDP — Medpace Holdings, Inc.

Company Identity

CIK0001672688
TickerABSI
ExchangeNasdaq
SIC8731: Services-Commercial Physical & Biological Research
Websitehttps://www.absci.com
Listed2021-07-22

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 6e8597418d0ae1699ec0f92b59684c2ad64e44d56db038a315e27e8d73be5f45
parent: 9f2c0ccf3e7a233e62205f9827986dc6d18f50ae6ba7ef06cefe1afd1e5b26e9
content hash: 07f8c11855756a3abfa937b178e4b2598c7a295d45057dd7aaa2d3b6cd356f0c
signed: 2026-06-02T19:00:02.701Z
sources: 18 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf